Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2024-04-03 Capital/Financing Update
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
Capital/Financing Update Classification · 99% confidence The document is a news release from aap Implantate AG, dated April 3, 2024, announcing the 100% approval by bondholders to amend the terms and conditions of a mandatory convertible bond (2023/2028). This announcement details a change in financing/capital structure (amendment to bond terms, granting early conversion rights). This falls directly under the definition of 'Capital/Financing Update' (CAP). Although it relates to debt instruments, the core event is the successful vote and amendment of the bond terms, which is a financing activity, rather than an interest rate change (IRAT) or a general regulatory filing (RNS). Given the content focuses entirely on the successful vote and resulting change to the bond terms, CAP is the most appropriate classification.
2024-04-03 English
aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated March 18, 2024, explicitly titled 'aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights'. It details a resolution by the Management Board to increase the share capital by issuing new shares for cash contributions, which is a direct action related to the company's capital structure and financing activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV).
2024-03-18 English
aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated March 5, 2024, disclosing 'Inside information acc. to Article 17 MAR'. The content discusses a proposal to amend the terms and conditions of a mandatory convertible bond (2023/2028) to allow for earlier exercise of conversion rights. This is a specific corporate action related to financing/capital structure, but it is primarily an announcement of a proposed change requiring a vote, rather than a final financing document (CAP) or a general regulatory filing (RNS). Reviewing the definitions: - It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). - It relates to a bond, which touches upon Capital/Financing (CAP), but the core action is announcing the process for amending the bond terms and soliciting a vote from bondholders. - It is not a Director's Dealing (DIRS), Dividend Notice (DIV), or Management Discussion (MDA). - Since it involves a specific corporate action announcement that doesn't fit neatly into the primary financial reporting categories (10-K, IR, ER) or specific corporate events (M&A, DIV, DIRS), and it is a mandatory disclosure under MAR (EU regulation), it falls best under the general regulatory announcement category. - While it involves a vote, it is a vote by bondholders on terms, not a general shareholder vote (DVA) or proxy solicitation (PSI). Therefore, the most appropriate general classification for a specific, material, non-standard corporate disclosure is Regulatory Filings (RNS).
2024-03-05 English
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
Earnings Release Classification · 100% confidence The document is a news release dated February 15, 2024, titled 'After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year'. It explicitly mentions 'Key word(s): Interim Report/Corporate Action' and provides key highlights for the start of the 2024 financial year, including sales figures and clinical trial updates. It summarizes performance for a period shorter than a full year (start of 2024 vs. 2023), which strongly indicates an Interim Report (Quarterly or Half-Yearly). Since it provides key results and operational updates rather than just announcing the availability of a full report, it fits the 'Interim / Quarterly Report' (IR) definition better than 'Report Publication Announcement' (RPA). The document length (7565 chars) is substantial enough to contain summary results, not just a brief announcement. FY 2023
2024-02-15 English
More than 100 patients included in the human clinical trial by 31 December 2023; adapted study design meets expectations for accelerated patient recruitment
Environmental & Social Information Classification · 99% confidence The document is explicitly labeled as "EQS-Media" and "News Details" and is dated 10 January 2024. It discusses operational updates regarding a clinical trial, patient recruitment milestones, future market launch expectations, and funding sources (BMBF). This format—a press release detailing recent operational achievements and future outlook, rather than a formal regulatory filing like a 10-K or a detailed financial report like an IR—is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it focuses on operational progress and milestones rather than just the final quarterly numbers, it fits best as an Earnings Release (ER) which often includes operational highlights, or potentially a Regulatory Filing (RNS) if it were less focused on performance metrics. Given the content focuses on clinical trial progress and recruitment targets, which are key performance indicators often highlighted in earnings communications, ER is the most appropriate fit among the specific financial codes. It is not a full financial report (IR/10-K) nor a transcript (CT).
2024-01-10 English
aap concludes distribution agreement for LOQTEQ VA Radius System with leading global spine and orthopedics company
Regulatory Filings Classification · 100% confidence The document is a news release dated January 9, 2024, announcing the conclusion of a distribution agreement for a medical device (LOQTEQ® VA Radius System). It uses keywords like 'EQS-News', 'Corporate News', and discusses business strategy and expected volume. This type of announcement, which is a material business event but not a formal financial report (like 10-K or IR) or a specific insider/dividend action, typically falls under general regulatory announcements or news releases. Since it is a specific business update disseminated via a news service (EQS), and it doesn't fit the definitions for ER, CAP, MANG, or DIRS, the most appropriate general category for a significant, non-financial-statement corporate event announcement is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements.
2024-01-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.